Regeneron Pharmaceuticals Inc. stocks have been trading up by 12.06 percent after positive trial data boosted investor confidence Key Takeaways Late Phase 3 C-POST follow-up showed Libtayo cut risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results